How Long Does Kidney Failure Last Before Death?

Learn the true prognosis for kidney failure patients. Understand survival timelines with and without life-sustaining treatment.

Kidney failure can last anywhere from a few days to several years before death, depending on whether the person receives dialysis, how quickly the kidneys failed, and how many other health problems are present. When someone stops dialysis or chooses not to start it, the timeline typically narrows to days or months. The range is genuinely enormous: studies report median survival without dialysis anywhere from about one month to nearly four years, which reflects just how much individual circumstances matter.

After Dialysis Stops

For people already on dialysis who decide to discontinue treatment, death tends to follow within roughly one to two weeks. One study of 18 patients found a mean survival of about 10 days after stopping hemodialysis. A larger study tracking 126 patients reported a mean survival of about eight days, with half dying within six days. A handful lived between 30 and 46 days, but they were outliers. The reason the window is so short is that dialysis was doing the kidneys’ essential work: clearing toxins, removing excess fluid, and balancing electrolytes. Once that stops, waste products build up quickly and the body begins to shut down.

This timeline is specific to people whose kidneys have essentially no remaining function. Someone whose kidneys still filter a small amount of blood may last somewhat longer, because that residual function buys a little extra time even without the machine.

Living With Kidney Failure Without Dialysis

Not everyone with kidney failure starts dialysis. Some people, especially older adults or those with serious additional illnesses, choose what doctors call conservative kidney management: treating symptoms and maintaining quality of life without dialysis. The survival numbers for this group vary widely. A systematic review found that median survival under conservative management was at least six months, with individual study estimates ranging from about six to 23 months. A more recent review found even broader variation: median survival from one to 45 months, with one-year survival rates spanning roughly 29% to 82%.

That enormous spread is not a sign of sloppy research. It reflects real differences in the patients studied: how old they were, how fast their kidney function was declining, what other conditions they had, and at what point the “clock” started ticking. A relatively healthy 70-year-old with slowly worsening kidneys and no heart disease is living in a completely different biological situation than an 85-year-old with diabetes, heart failure, and rapidly falling kidney function.

Sudden Kidney Failure Is a Different Story

Everything above applies to chronic kidney failure, where kidney function erodes over months or years. Acute kidney injury is a separate scenario: the kidneys stop working suddenly, often because of severe infection, a medication reaction, a blockage in the urinary tract, or a major drop in blood pressure during surgery or critical illness. When acute kidney injury happens in a hospital setting, it can be immediately life-threatening. A large study of over 71,000 hospitalized patients found that those who developed acute kidney injury on top of ongoing kidney damage had a hospital death rate of about 16%, compared with roughly 1.3% in patients without kidney problems.

The crucial difference is that acute kidney injury is sometimes reversible. If doctors can treat the underlying cause quickly enough, the kidneys may recover partially or even fully. When they do recover, long-term survival improves dramatically. But even people whose acute injury resolves face higher mortality later: each unit of decline in kidney function from baseline increases the risk of death down the road, with the risk climbing steeply as residual function drops into the most advanced stages of chronic kidney disease.

How Age and Other Health Conditions Change the Timeline

Age alone matters, but it is far from the whole picture. A large systematic overview of dialysis patients found that each additional year of age increased the relative risk of death by about 3%. Diabetes roughly doubled the risk. Heart disease and peripheral vascular disease each increased it by about 60%. These numbers help explain why survival estimates are so variable: a person’s total burden of illness is a better predictor than kidney function alone.

In the general population with reduced kidney function, the cause of death shifts as the kidneys worsen. Among those with mild kidney impairment, cancer is the leading killer. But as kidney function drops, cardiovascular disease takes over. In people with the most advanced kidney impairment short of dialysis, cardiovascular disease accounted for nearly 44% of deaths, compared with about 21% in those with milder impairment. Deaths from heart failure and infections also climbed as kidney function declined. This means that for many people with kidney failure, it is not the kidney failure itself that kills them directly but a cardiovascular event or overwhelming infection accelerated by their failing kidneys.

Does Dialysis Actually Extend Life, and for Whom?

On average, yes. A meta-analysis pooling adjusted results from 12 studies found that patients who chose dialysis had roughly half the mortality risk compared with those managed conservatively. A UK study of patients over 75 found one-year survival of 84% in the dialysis group versus 68% in the conservative group, and two-year survival of 76% versus 47%.

But the benefit shrinks considerably in the oldest and sickest patients. A large comparative study found that the survival advantage of dialysis disappeared in patients aged 80 and older: median survival was about two years with dialysis versus roughly a year and a half without, and the difference was not statistically meaningful. Among patients 70 and older who had high comorbidity scores, especially cardiovascular disease, the gap narrowed substantially as well. A separate study found that adjusted median survival from the time of enrollment was about 13 months shorter for conservative management patients, but their quality of life remained stable, whereas life satisfaction actually declined after patients started dialysis.

A systematic review and meta-analysis that looked specifically at elderly patients concluded that the available evidence shows broadly similar one-year survival between dialysis and supportive care, and that the data do not yet allow a confident estimate of which approach is better for this age group. This is where the decision becomes deeply personal, turning on whether additional months of life outweigh the burden of treatment.

What the Final Weeks and Days Feel Like

Whether someone is on conservative care or has stopped dialysis, the last weeks of life with kidney failure carry a heavy symptom burden. A study of patients in the final month of life with advanced kidney disease found a median of roughly 17 symptoms, rising to over 20 when kidney-specific symptoms were included. More than 80% of patients experienced a lack of energy, itching, drowsiness, and shortness of breath. Pain affected about three-quarters. Poor appetite, swelling in the arms and legs, dry mouth, constipation, and nausea each affected more than half. Among these, shortness of breath was reported as disproportionately distressing relative to how common it was.

As waste products continue to accumulate, the brain is affected too. Uremic encephalopathy, the neurological syndrome caused by toxin buildup, can progress from mild confusion and difficulty concentrating to delirium and eventually coma. Tremors, involuntary jerking movements, and seizures may occur as the condition worsens. In the final days, increasing drowsiness and reduced consciousness are common. Many patients slip into a state of deep sleepiness and eventually become unresponsive before dying. For families, knowing this pattern in advance can reduce some of the fear around what is happening.

Palliative and Supportive Care

Symptom relief during end-stage kidney failure has its own set of challenges because the kidneys normally help process and eliminate many medications. Pain relievers, sedatives, and anti-nausea drugs may build up faster than expected, requiring careful dose adjustments. UK guidelines developed specifically for dying patients with advanced kidney disease focus on controlling the same core symptoms seen at the end of life in other conditions: pain, breathlessness, agitation and restlessness, nausea, and excess secretions in the airway.

Formal renal supportive care programs, which pair nephrology with palliative care teams, have shown meaningful benefits beyond survival. One observational study found that patients enrolled in such a program spent significantly fewer days in the hospital per year (roughly 47 versus 83 days) and had fewer admissions (about five per year versus 12), even though overall survival from the point of very low kidney function was similar between groups. Spending less time in the hospital without shortening life is a tangible gain in quality of life during a period when every day matters.

Why Individual Predictions Are So Difficult

Researchers have built dozens of models trying to predict how long a given person with kidney failure will live. A systematic review identified 50 different mortality prediction models that included nearly three million participants in total, with time horizons ranging from three months to 10 years. Another review found that imaging of the heart, particularly assessing how well it pumps and how much strain it is under, is one of the more useful prognostic tools for kidney disease patients. Even a seemingly technical measure like fluid overload has predictive power: patients whose body water exceeded a healthy baseline by more than 15% had more than double the mortality risk.

Despite all these models, predicting survival for any single person remains frustratingly imprecise. Models work at the population level: they can tell you that people with certain characteristics tend to live longer or shorter. They cannot tell you that your father will die in four months or your spouse in two years. This uncertainty makes advance care planning difficult, and studies have found that many dialysis patients have limited understanding of end-of-life terminology and few opportunities for meaningful conversations about what to expect.

Children With Kidney Failure

The picture in children looks quite different from adults. Most children with end-stage kidney disease receive transplants, which dramatically improves their outlook compared with long-term dialysis. A large study using U.S. registry data found that children treated with dialysis had a mortality risk more than four times higher than those who received a kidney transplant. Among children starting any form of treatment, the youngest, those under one year old, faced the highest risk of death, about four times that of teenagers aged 15 to 19. The biological reasons are complex, but very young children are more vulnerable to fluid and electrolyte instability, and transplantation is technically more challenging in the smallest patients. For families facing this situation, the path to transplant is generally the strongest predictor of long-term survival.

What Caregivers Go Through

The uncertainty that makes medical prediction so hard also weighs heavily on families. A systematic review of caregiver experiences found that caregivers of people managed conservatively reported specific anxiety about the process of deterioration and dying, worries about managing the practical aspects of death at home, and distress amplified by not knowing when death would come. Many coped by focusing on the present and pushing future concerns aside, but this same strategy led to reluctance to discuss end-of-life issues openly with the patient.

Interestingly, caregivers of people on dialysis did not necessarily fare better emotionally than those caring for someone on conservative management. A study comparing the two groups found that caregivers of dialysis patients actually reported a significantly worse caregiving experience after adjusting for background characteristics, even though their own overall health-related quality of life was similar. Dialysis imposes its own burdens on the household: transport to treatment centers several times a week, managing dietary restrictions, and dealing with the patient’s post-treatment fatigue. Conservative care has a more open-ended uncertainty, but the day-to-day demands on the caregiver can be lower. Neither path is easy, and caregiver wellbeing deserves attention in its own right during the treatment decision.